2022 Microbiome Consortium Symposium

The 2022 NCBC Microbiome Symposium will take place on Wednesday, May 25 from 8:30 am to 4:30 pm at the North Carolina Biotechnology Center. It will feature an exciting day of presentations and additional activities, including poster sessions, networking time, and lunch.

Keynote speaker: Dr. Ralph Baric 

This will be an excellent opportunity for researchers to reconnect with fellow academia and industry scientists!

To access speaker and panelist bios, please use the link at the top of the page.


8:30 am              Registration and coffee/breakfast

8:50 am              Welcome – NC Microbiome Consortium Organizing Committee Member

9:00 am              Session 1: COVID-19 and Microbiome Research in North Carolina

"SARS-CoV-2: From diagnostics to genomic collaborations"

Melissa Miller, Ph.D., Professor, Department of Pathology and Laboratory Medicine, the University of North Carolina at Chapel Hill, and Director of the Clinical Microbiology and Molecular Microbiology Laboratories at UNC Hospitals

Matthew Kelly, MD, Associate Professor of Pediatrics, Associate Professor of Global Health, Duke University

10:00 am            Refreshment Break

Posters and Networking

10:30 am            Session 2: Innovation in Microbiome Analysis

"Metabolomics informs Precision Nutrition and Precision Medicine"

Susan Sumner, Ph.D., Professor of Nutrition at UNC-Chapel Hill’s Nutrition Research Institute, and Director of the Metabolomics and Exposome Laboratory, the University of North Carolina at Chapel Hill

"Rationally designed bacterial consortia to treat chronic-immune-mediated colitis and restore intestinal homeostasis"

Daniel van der Lelie, PhD

CEO and CSO, Gusto Global

12:00 pm           Lunch

                            Poster Session and Networking

1:30 pm              Session 3: Regulation of Microbiome-Based Products

"Regulatory considerations for microbiome-based therapeutics"       

Paul Carlson, Ph.D.

Principal Investigator, Lab of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Office of Vaccines Research and Review, FDA

"Societal Dimensions of Governance for Microbiome Engineering"

Jennifer Kuzma, Ph.D.

Goodnight-NCGSK Foundation Distinguished Professor & Co-Director of the Genetic Engineering and Society Center, School of Public and International Affairs, North Carolina State University


Ward Peterson, Ph.D., Chairman & CEO, Symberix

Carmella Moody, Ph.D., Director for Regulatory Affairs, RTI

2:30 pm              Session 4: Industry Research in the Triangle

"Bacteriophage treatment of microbiome diseases"

Hannah Tuson, Ph.D., Director of Discovery, Locus Biosciences

"AgBiome: Partnering with the Microbial World for Human Benefit"

Tracy Raines, PhD

R&D Business Development, AgBiome


Nathan Cude, Ph.D., Sr. Scientist II, Novozymes

Yong Jun Goh, Ph.D., Senior Microbiologist, AgBiome

3:30 pm              Keynote Speaker:

"Mechanisms of Sarbocoronavirus pathogenesis"

Ralph Baric, Ph.D., William R. Kenan, Jr. Distinguished Professor, Department of Epidemiology, Professor, Department of Microbiology and Immunology, the University of North Carolina at Chapel Hill

4:30 pm              Closing and adjourn


Free parking available on-site

Speaker and Panelist Bios


Session 1: COVID-19 and Microbiome Research in North Carolina


Melissa Miller, PhD, is a Professor of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill School of Medicine. She is also the Director of the Clinical Microbiology and Molecular Microbiology Laboratories for UNC Medical Center. She received her Ph.D. in Molecular Biology from Princeton University and completed the Medical and Public Health Microbiology Fellowship at UNC Hospitals. She is the chair of the American Society for Microbiology Clinical and Public Health Microbiology Committee, a Fellow of the American Academy of Microbiology, and an Editor for the Journal of Clinical Microbiology. Dr. Miller’s research interests include the development of accurate and cost-effective molecular tests for viral infections and the assessment of patient and healthcare outcomes associated with the implementation of new molecular technologies. She received the 2021 ASM Award for Research and Leadership in Clinical Microbiology and was a co-recipient of the 2021 ASM Special Recognition Award for leadership during the COVID-19 pandemic. Dr. Miller is also the recipient of the NC Governor’s Award for Excellence in Public Service, which is the highest honor a state employee can receive for dedicated service to the State of North Carolina and its citizens.


Matthew Kelly, MD, is an Assoicate Professor of Pediatrics and an Assoicate Research Professor of Global Health at Duke University. His research is broadly focused on elucidating the complex interactions that exist between the host microbiome and exogenous pathogens that cause infections in children. There are several ongoing projects evaluating: 1) the impact of the upper respiratory microbiome on the risk of colonization and invasion by bacterial respiratory pathogens among infants in Botswana; 2) associations between the gut microbiome of pediatric stem cell transplant recipients and the risk of infections (bloodstream infection, C. difficile infection) and graft-versus-host disease; and 3) the role of the gut and respiratory microbiomes in mediating COVID-19 infection susceptibility and disease severity in children. Ultimately, Dr. Kelly aims to develop strategies that use targeted modification of the microbiome for the prevention of infections in children.


Session 2: Innovation in Microbiome Analysis